Chihao Zhang

890 total citations
45 papers, 610 citations indexed

About

Chihao Zhang is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Chihao Zhang has authored 45 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 20 papers in Hepatology and 17 papers in Epidemiology. Recurrent topics in Chihao Zhang's work include Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (16 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Chihao Zhang is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (16 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Chihao Zhang collaborates with scholars based in China, United States and France. Chihao Zhang's co-authors include Jiayun Lin, Yiming Zhu, Qingwei Zhang, Meng Luo, Jiwei Yu, Lei Zheng, Meng Luo, Xiaochun Ni, Xin Xu and Meng Luo and has published in prestigious journals such as Frontiers in Immunology, Experimental Cell Research and European Journal of Pharmacology.

In The Last Decade

Chihao Zhang

41 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chihao Zhang China 19 210 182 180 175 145 45 610
Takayoshi Kaida Japan 16 273 1.3× 159 0.9× 143 0.8× 401 2.3× 137 0.9× 44 761
Kenji Wakayama Japan 14 312 1.5× 103 0.6× 135 0.8× 143 0.8× 123 0.8× 58 647
Shubing Zou China 16 219 1.0× 185 1.0× 162 0.9× 235 1.3× 74 0.5× 30 596
Shinichi Nakanuma Japan 18 202 1.0× 173 1.0× 122 0.7× 322 1.8× 113 0.8× 93 752
Naohiro Hosomura Japan 14 287 1.4× 104 0.6× 203 1.1× 305 1.7× 111 0.8× 68 662
Yongjie Shui China 15 146 0.7× 207 1.1× 154 0.9× 206 1.2× 62 0.4× 32 648
Yota Kawasaki Japan 14 223 1.1× 215 1.2× 190 1.1× 308 1.8× 76 0.5× 71 643
Keishi Nakamura Japan 14 144 0.7× 130 0.7× 168 0.9× 227 1.3× 66 0.5× 57 585
Homare Ito Japan 10 120 0.6× 237 1.3× 191 1.1× 122 0.7× 74 0.5× 25 522
Shengjie Jin China 18 273 1.3× 190 1.0× 166 0.9× 183 1.0× 259 1.8× 80 839

Countries citing papers authored by Chihao Zhang

Since Specialization
Citations

This map shows the geographic impact of Chihao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chihao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chihao Zhang more than expected).

Fields of papers citing papers by Chihao Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chihao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chihao Zhang. The network helps show where Chihao Zhang may publish in the future.

Co-authorship network of co-authors of Chihao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Chihao Zhang. A scholar is included among the top collaborators of Chihao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chihao Zhang. Chihao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhao, Zhifeng, Qiang Fan, Chihao Zhang, et al.. (2024). Imperatorin attenuates CCl4-induced cirrhosis and portal hypertension by improving vascular remodeling and profibrogenic pathways. European Journal of Pharmacology. 980. 176833–176833. 3 indexed citations
3.
Zhang, Chihao, Wei Ni, Yiming Zhu, et al.. (2022). Construction and comprehensive analysis of a lncRNA–mRNA interactive network to reveal a potential lncRNA for hepatic encephalopathy development. Human Cell. 35(4). 1060–1070. 2 indexed citations
4.
Zhao, Zhifeng, Yanna Zhao, Wenjuan Xu, et al.. (2022). Salivary biomarkers-assisted ultrasound-based differentiation of malignant and benign thyroid nodules. Gland Surgery. 11(1). 196–206. 4 indexed citations
5.
Zhang, Chihao, Jiayun Lin, Xiaochun Ni, et al.. (2021). Prognostic Value of Serum Osteoprotegerin Level in Patients With Hepatocellular Carcinoma Following Surgical Resection. Frontiers in Oncology. 11. 731989–731989. 6 indexed citations
6.
Zhao, Zhifeng, Chihao Zhang, Jiayun Lin, et al.. (2021). COX-2/sEH Dual Inhibitor PTUPB Alleviates CCl4-Induced Liver Fibrosis and Portal Hypertension. Frontiers in Medicine. 8. 761517–761517. 8 indexed citations
7.
Lin, Jiayun, Chihao Zhang, Lei Zheng, et al.. (2020). Assessment of a biofluid mechanics-based model for calculating portal pressure in canines. BMC Veterinary Research. 16(1). 308–308. 1 indexed citations
8.
Zhu, Yiming, et al.. (2020). Noninvasive Photochemical Sealing for Achilles Tendon Rupture by Combination of Upconversion Nanoparticles and Photochemical Tissue Bonding Technology. BioMed Research International. 2020(1). 1753152–1753152. 6 indexed citations
9.
Zheng, Lei, Chihao Zhang, Jiayun Lin, et al.. (2020). Comparative Effectiveness of Radiofrequency Ablation vs. Surgical Resection for Patients With Solitary Hepatocellular Carcinoma Smaller Than 5 cm. Frontiers in Oncology. 10. 399–399. 20 indexed citations
10.
Zhang, Chihao, et al.. (2020). Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis. Translational Oncology. 14(1). 100875–100875. 20 indexed citations
11.
Zhang, Qingwei, Chihao Zhang, Yuan‐Bo Pan, et al.. (2020). Prognosis of colorectal cancer patients is associated with the novel log odds of positive lymph nodes scheme: derivation and external validation. Journal of Cancer. 11(7). 1702–1711. 13 indexed citations
12.
Pan, Yuanbo, Yiming Zhu, Qingwei Zhang, et al.. (2020). Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis. Frontiers in Oncology. 10. 1057–1057. 19 indexed citations
13.
Zhao, Zhifeng, Yeping Yu, Dan Xu, et al.. (2020). Prognostic value of the creatinine-albumin ratio in acute pancreatitis debridement. BMC Surgery. 20(1). 322–322. 23 indexed citations
15.
Xu, Xin, Chihao Zhang, Xiaochun Ni, et al.. (2019). Population-based analysis on predictors for lymph node metastasis in T1 colon cancer. Surgical Endoscopy. 34(9). 4030–4040. 20 indexed citations
18.
Pan, Yuan‐Bo, Chihao Zhang, Siqi Wang, et al.. (2018). Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma. Journal of Neuro-Oncology. 137(2). 395–407. 32 indexed citations
19.
Sun, Dong, Houli Jiang, Lei Zheng, et al.. (2017). Inhibition of soluble epoxide hydrolase reduces portal pressure by protecting mesenteric artery myogenic responses in cirrhotic rats. Prostaglandins & Other Lipid Mediators. 131. 17–24. 5 indexed citations
20.
Zheng, Lei, Jun Qin, Longci Sun, et al.. (2016). Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension. Clinics and Research in Hepatology and Gastroenterology. 41(3). 303–310. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026